Capstone Therapeutics Corp. 4
4 · Capstone Therapeutics Corp. · Filed May 21, 2012
Insider Transaction Report
Form 4
HOLLIMAN JOHN M III
DirectorExecutive Chairman
Transactions
- Award
Stock Option (Right to Buy)
2012-05-18+65,000→ 720,000 totalExercise: $0.17From: 2013-05-18Exp: 2022-05-18→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]50% vest immediately and 50% on 5/18/2013